Key Points
- Mario Schlosser sold 23,038 Oscar Health shares on Jan 8 at an average price of $17.65 for $406,620.70 and has sold multiple blocks in recent months totaling roughly $7.07 million, leaving him with 350,180 shares (a 6.17% ownership decline).
- Oscar Health shares trade around $17.68 (12‑month range $11.20–$23.80) with a $4.68B market cap and a negative PE; the company showed 23.2% revenue growth and a slight EPS beat last quarter, but analysts' average rating is "Reduce" with an average $17 price target.
Oscar Health, Inc. (NYSE:OSCR - Get Free Report) insider Mario Schlosser sold 23,038 shares of the business's stock in a transaction that occurred on Thursday, January 8th. The stock was sold at an average price of $17.65, for a total transaction of $406,620.70. Following the sale, the insider owned 350,180 shares of the company's stock, valued at approximately $6,180,677. This represents a 6.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Mario Schlosser also recently made the following trade(s):
- On Tuesday, January 6th, Mario Schlosser sold 76,962 shares of Oscar Health stock. The shares were sold at an average price of $17.01, for a total transaction of $1,309,123.62.
- On Wednesday, December 24th, Mario Schlosser sold 38,835 shares of Oscar Health stock. The stock was sold at an average price of $15.00, for a total transaction of $582,525.00.
- On Tuesday, December 2nd, Mario Schlosser sold 23,965 shares of Oscar Health stock. The shares were sold at an average price of $16.59, for a total value of $397,579.35.
- On Tuesday, November 11th, Mario Schlosser sold 286,182 shares of Oscar Health stock. The shares were sold at an average price of $15.27, for a total value of $4,369,999.14.
Oscar Health Trading Down 0.3%
Shares of OSCR opened at $17.68 on Tuesday. Oscar Health, Inc. has a 12 month low of $11.20 and a 12 month high of $23.80. The stock's 50-day moving average is $15.80 and its two-hundred day moving average is $16.91. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.92 and a quick ratio of 0.92. The stock has a market cap of $4.68 billion, a PE ratio of -15.78 and a beta of 1.90.
Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Thursday, November 6th. The company reported ($0.53) EPS for the quarter, beating the consensus estimate of ($0.55) by $0.02. The business had revenue of $2.93 billion for the quarter, compared to the consensus estimate of $3.09 billion. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.The company's revenue was up 23.2% on a year-over-year basis. During the same period last year, the business posted ($0.22) EPS. Equities analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in the stock. LRI Investments LLC increased its position in shares of Oscar Health by 377.9% in the 2nd quarter. LRI Investments LLC now owns 1,233 shares of the company's stock worth $26,000 after purchasing an additional 975 shares during the last quarter. Farther Finance Advisors LLC lifted its position in shares of Oscar Health by 4,420.7% during the third quarter. Farther Finance Advisors LLC now owns 1,311 shares of the company's stock worth $25,000 after purchasing an additional 1,282 shares during the last quarter. Atlantic Union Bankshares Corp acquired a new position in Oscar Health in the second quarter worth about $33,000. Quarry LP grew its stake in Oscar Health by 439.8% in the third quarter. Quarry LP now owns 1,803 shares of the company's stock worth $34,000 after purchasing an additional 1,469 shares in the last quarter. Finally, Tsfg LLC bought a new stake in Oscar Health in the third quarter valued at about $38,000. 75.70% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of research firms have recently commented on OSCR. UBS Group raised shares of Oscar Health from a "sell" rating to a "neutral" rating and boosted their target price for the stock from $12.00 to $17.00 in a research report on Friday. Zacks Research raised shares of Oscar Health from a "strong sell" rating to a "hold" rating in a research note on Monday, October 13th. The Goldman Sachs Group began coverage on shares of Oscar Health in a research report on Tuesday, October 14th. They issued a "neutral" rating and a $17.00 price objective for the company. Wells Fargo & Company lowered their target price on Oscar Health from $14.00 to $11.00 and set an "underweight" rating for the company in a research note on Thursday, November 13th. Finally, Weiss Ratings reaffirmed a "sell (d)" rating on shares of Oscar Health in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, Oscar Health presently has an average rating of "Reduce" and an average price target of $17.00.
Get Our Latest Analysis on Oscar Health
About Oscar Health
(
Get Free Report)
Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.
The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
